Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
Leone JP, Emblem KE, Weitz M, Gelman RS, Schneider BP, Freedman RA, Younger J, Pinho MC, Sorensen AG, Gerstner ER, Harris G, Krop IE, Morganstern D, Sohl J, Hu J, Kasparian E, Winer EP, Lin NU. Leone JP, et al. Among authors: krop ie. Breast Cancer Res. 2020 Nov 30;22(1):131. doi: 10.1186/s13058-020-01372-w. Breast Cancer Res. 2020. PMID: 33256829 Free PMC article. Clinical Trial.
HIN-1, an inhibitor of cell growth, invasion, and AKT activation.
Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K. Krop I, et al. Cancer Res. 2005 Nov 1;65(21):9659-69. doi: 10.1158/0008-5472.CAN-05-1663. Cancer Res. 2005. PMID: 16266985
A putative role for psoriasin in breast tumor progression.
Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K. Krop I, et al. Cancer Res. 2005 Dec 15;65(24):11326-34. doi: 10.1158/0008-5472.CAN-05-1523. Cancer Res. 2005. PMID: 16357139
Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.
Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, Gelman R, Schnitt SJ, Krop IE, Polyak K. Kleer CG, et al. Among authors: krop ie. Clin Cancer Res. 2008 Sep 1;14(17):5357-67. doi: 10.1158/1078-0432.CCR-08-0732. Clin Cancer Res. 2008. PMID: 18765527 Free PMC article.
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.
Mina L, Krop I, Zon RT, Isakoff SJ, Schneider CJ, Yu M, Johnson C, Vaughn LG, Wang Y, Hristova-Kazmierski M, Shonukan OO, Sledge GW, Miller KD. Mina L, et al. Invest New Drugs. 2009 Dec;27(6):565-70. doi: 10.1007/s10637-009-9220-1. Epub 2009 Feb 13. Invest New Drugs. 2009. PMID: 19214387 Clinical Trial.
Mechanisms of trastuzumab resistance in breast cancer.
Tolaney SM, Krop IE. Tolaney SM, et al. Among authors: krop ie. Anticancer Agents Med Chem. 2009 Mar;9(3):348-55. doi: 10.2174/1871520610909030348. Anticancer Agents Med Chem. 2009. PMID: 19275526 Review.
235 results